Form4insider filings, from the source

SEC Form 4/A · accession 0001104659-15-030980

LIGAND PHARMACEUTICALS INC · LGND

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Period of report
Apr 24, 2015
Accepted (ET)
Apr 28, 2015 · 4:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000886163

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Apr 24, 2015A925$0.00A26,622D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Non-Qualified Stock Option (right to buy)F2$89.75Apr 24, 2015A2,754A—Apr 24, 2025Common Stock2,7542,754D
Non-Qualified Stock Option (right to buy)F3$67.53holding————Jun 4, 2024Common Stock3,3123,312D

Explanation of responses

Remarks

In addition to the new awards reflected on this filing, this filing is being made to correct the number of securiites in column 5 of Table I, which reflects shares previously reported on the Form 4 filing made on November 14, 2011.